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1. Introduction 
1.1. Adhesion receptor β1-Integrin 
 
β1-Integrin, a subunit of the Integrin receptor family, plays a key role as a regulator of 
both development biology and the formation of cancer (Brakebusch et al. 1997; Fassler 
and Meyer 1995; Lahlou and Müller 2011; Morello et al. 2011; Stephens et al. 1995; 
White et al. 2004).  
In general an Integrin consists of one α and one β subunit (Hynes 2002). 18 different α 
subunits and 8 different β subunits, which form 24 Integrin heterodimers, have been 
found in organisms. Remarkably, 12 of these Integrin heterodimers contain the β1-
Integrin subunit (Hynes 2002).This fact emphasizes its great importance additionally to 
its ubiquitous expression. 
 
 
 
 
 
Figure 1 (Modified from (Weinberg 2007)) Schematic structure of Integrins. The α subunit (blue) and the β 
subunit (red) form a heterodimer of Integrin, a transmembrane adhesion cell receptor, spanning the cell 
membrane once. The outer domain of the Integrin attaches the cell to components of extracellular matrix 
(ECM) or adjacent cells. The intracellular domain of Integrin mediates the connection to the cytoskeleton 
by linking proteins. 
A special feature of Integrins is their ability to signal bidirectionally (Hynes 2002) 
without being enzymatically active (Liu et al. 2000). Integrins are involved in 
cytosol 
plasma 
membrane 
extracellullar-binding site binds 
to the extracellular matrix 
α subunit  β subunit  
intracellular-binding site 
binds to the 
cytoskeleton 
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proliferation, apoptosis, migration and differentiation processes of cells (Hu and Luo 
2012; Hynes 2002). 
These are essential steps of developmental biology and as formerly shown, β1-Integrin 
is crucial for the early development of the mouse embryo. Mice with a homozygous, 
constitutive knockout of β1-Integrin die around E6.5 (embryonic age day 6.5) because 
of degenerative growth of the inner cell mass of the blastocyst (Brakebusch et al. 1997; 
Fassler and Meyer 1995; Stephens et al. 1995).  
In further development of the organism β1-Integrin is critical especially in the formation 
of mammary gland (Klinowska et al. 1999; Li et al. 2005; Liu et al. 2000; Naylor et al. 
2005) and the development of the skeletal muscle (Brakebusch et al. 1997; Burkin et 
al. 2001; Schwander et al. 2003). 
The fact that β1-Integrin is also important for the development of the cerebral and 
cerebellar cortex is of special interest for this research project (Belvindrah et al. 2007; 
Blaess et al. 2004; Dulabon et al. 2000; Graus-Porta et al. 2001; Rice and Curran 
2001). 
 
Breast cancer is a prime example that β1-Integrin is not only decisive in developmental 
processes but also in cancer formation (Lahlou and Müller 2011). In a genetically 
modified mouse model, White et al. showed that β1-Integrin is responsible for the 
induction and maintenance of breast cancer (White et al. 2004). Moreover, increased 
β1-Integrin expression is correlated with a poor survival of human breast cancer 
patients. According to this, it may serve as a prognostic factor for these patients (Yao 
et al. 2007).  
In several studies it was shown that β1-Integrin has also notable effects on tumor 
recurrence, survival, progression and metastasis and is suggested to be a target for 
cancer therapies (Barkan and Chambers 2011; Cordes and Park 2007; Morello et al. 
2011; Park et al. 2006). 
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1.2. Cerebellar Development 
 
The adult cerebellum is organized in a well-defined, cortical laminar structure with only 
three layers (Palay and Chan-Palay 1974)(Figure 2). 
 
 
 
Figure 2 (modified from (Hatten 1999; Tanaka et al. 2008)) Schematic and simplified cross section of the  
adult cerebellar cortex consisting of three layers with the relevant cell types for this study. The granule 
layer contains the cerebellar granule neurons (blue), the Purkinje cell layer contains the Purkinje cells (red) 
and between them are the Bergmann glia cells located (green). The molecular layer contains the T-shaped 
parallel fibers of granule neurons, the dendritic arborisation of Purkinje cells and the Bergmann glia fibers. 
 
The cells of the CNS can be broadly divided into glial cells and neuronal cells, both 
differentiate from multipotential neural progenitor cells (Edlund and Jessell 1999). This 
study about cerebellar development focuses especially on cerebellar granule neurons 
and Bergmann glia.  
 
The cerebellar granule neuron is by far the most common cell type in the adult 
cerebellum and forms the innermost granule layer. The following Purkinje cell layer is a 
monolayer of fan-shaped Purkinje neurons with dentritic arborisation (Palay and Chan-
Palay 1974) (Figure 2). The cell bodies of the Bergmann glia lie in the region of the cell 
bodies of Purkinje cells and their fibers pass the outermost molecular layer to the pial 
surface (Grosche et al. 2002; Welsch 2006). In addition to the Bergmann glial fibers 
also the processes of the cerebellar granule neurons, the parallel fibers, and the dentric 
arborisation of the Purkinje cells extend into the molecular layer (Figure 2). 
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At the first glance the histological structure of the cerebellar cortex seems quite simple, 
even more notable is that the function of the cerebellum is more complex than 
previously assumed. In addition to the well-known motor coordination and control 
functions of the human cerebellum, its contribution in higher cognitive functions is also 
suggested by observation of clinical cases and fMRI studies (Fiez 1996; Ramnani 
2006). 
The cerebellum develops in highly organized processes of proliferation, differentiation, 
migration and forming circuitry of cells (Altman J 1997). The fourth ventricle is located 
dorsal of the developing embryo and forms a rhomboid-shaped gap in the neural tube. 
The fourth ventricle is bordered on its outer edge by the rhombic lip. Rostral from the 
fourth ventricle the cerebellar anlage is generated. Purkinje cells and inhibitory 
interneurons originate from the ventricular zone above the fourth ventricle. Then the 
postmitotic Purkinje cell precursors migrate along the emerging radial glial fibers into 
the interior of the developing cerebellar anlage and arrange in a monolayer (Misson et 
al. 1988). Meanwhile the cerebellar granule neuron precursors (CGNPs) arise from the 
upper rhombic lip proliferate there and move rostral to cover the cerebellar anlage in 
order to form there the external granule layer (EGL) (reviewed in (Hatten 1999; Hatten 
and Heintz 1995; Ten Donkelaar and Lammens 2009)). There the CGNPs proliferate 
enormously, approximately until the second week postnatal (Hatten and Heintz 1995; 
Miale and Sidman 1961; Roussel and Hatten 2011). During this phase, the Sonic 
hedgehog (Shh) protein, produced by Purkinje cells, is the major mitogen for CGNPs. If 
the EGL has reached its maximum thickness of about 8 cells, during further 
proliferation of the CGNPs the thickness of the EGL does not change, rather the 
horizontal extent of the EGL increases (Fujita 1967; Fujita et al. 1966). Then the EGL 
begins to decrease because postmitotic CGNPs differentiate and migrate along the 
Bergmann glial fibers below the Purkinje cell layer and form there the very compact 
internal granule layer (IGL). While they are migrating, the granule cells leave their 
extending axon, the T-shaped parallel fibers, behind in the molecular layer (Gao and 
Hatten 1993; Gao and Hatten 1994; Hatten and Heintz 1995). According to the 
observation that CGNPs adhere to and migrate along the Bergmann glial fibers on the 
way to their final position in the internal granule layer (IGL), it is supposed that 
adhesion receptors like β1-Integrin may be involved in these processes (Fishman and 
Hatten 1993; Hatten and Heintz 1995).  
In the terminal stage of cerebellar granule neuron differentiation, the cerebellar circuit 
network establishes and cerebellar granule neurons connect with mossy fibers and the 
dentritic arborisation of Purkinje cells (Hatten and Heintz 1995). 
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The knowledge of the development of the cerebellar cortex is obtained mainly by 
investigation on mutant mice, the prototype for this studies is the reeler mouse  (Hatten 
and Heintz 1995; Rice and Curran 1999). The reeler mouse is lacking reelin, a product 
of the reeler gene and mostly secreted by Cajal Retzius cells in the marginal zone. It is 
supposed that reelin modulates the neuronal-radial glial interplay and it was shown that 
reelin inhibits the neuronal migration. The result of the disruption of the reeler gene is 
an abnormal development of the cerebellum and cerebrum. The cerebellum, with a 
perturbated lamination, is reduced in size and the different cell layers of the cerebrum 
seem to be inverted. In vitro studies of Dulabon et al. connote the binding of Reelin to 
β1-Integrin and In Vivo experiments indicate that α3β1-Integrin is responsible for the 
proper function of reelin (Dulabon et al. 2000; Rice and Curran 1999).   
Furthermore, in a genetically modified mouse model lacking β1-Integrin in neural 
progenitors were observed laminar disorganization of cerebellar granule neurons and 
the fusion of folia in the cerebellum and of hemispheres of the cerebrum. These 
abnormalities were suggested to be caused by disorders in the marginal zone (Graus-
Porta et al. 2001). In the same mouse model a decreased size of the cerebellum was 
observed, Blaess et al. supposed that β1-Integrin may be critical for the proliferation of 
CGNPs (Blaess et al. 2004). In a further study Belvindrah et al. showed that β1-Integrin 
in radial glia is required for the proper lamination of the cerebral cortex (Belvindrah et 
al. 2007) and reactive gliosis in the forebrain was observed in a mouse model with a 
loss of β1-Integrin in glia (Robel et al. 2009). However, the specific role of β1-Integrin in 
glia and CGNPs in the cerebellar development is unknown. 
 
1.3 Medulloblastoma 
 
Medulloblastomas are a biological and clinical heterogeneous group of embryonal 
tumors arising in the cerebellum (Roussel and Hatten 2011) or brainstem (Gibson et al. 
2010; Grammel et al. 2012). Besides leukemia, medulloblastoma is one of the most 
common malignancies in childhood.  
A good knowledge of the cerebellar development is required in order to understand the 
formation of medulloblastoma. Mutations and deregulations of genes and pathways 
that are crucial for a correct cerebellar development can lead to its formation (Gibson et 
al. 2010; Roussel and Hatten 2011). Well investigated pathways of cerebellar 
development are the wingless pathway (WNT-pathway) and sonic hedgehog pathway 
(SHH-pathway), which show abnormal activation in medulloblastomas. Recently, these 
pathways gained on significance in molecular identification of the four distinct 
subgroups of medulloblastomas by the application of whole-genome and other 
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sequencing techniques (Kool et al. 2012; Northcott et al. 2011; Taylor et al. 2012). The 
WNT and SHH tumors represent two of these four genetic different subgroups. The 
other 2 subgroups, called the Group 3 and the Group 4, are molecularly not that well 
defined (Kool et al. 2012; Taylor et al. 2012)(Figure 3).  
 
 
Figure 3 (Taylor et al. 2012) The current consensus of molecular subgroups of medulloblastoma. Four 
distinct molecular subgroups were identified through transcriptional profiling studies from several research 
groups around the world. This overview summarizes the clinical, demographic and genetic data of the four 
subtypes. LCA= large cell/anaplastic tumors. 
 
However, medulloblastoma are still diagnosed according to the criteria of the 2007 
WHO classification of brain tumors (Louis et al. 2007) in clinical practice. Based on 
histological und immunhistochemical methods there are classic, desmoplastic, 
extensive nodular and large cell medulloblastomas. All subtypes of medulloblastoma 
are classified as tumors of highest malignancy, WHO grade IV (Louis et al. 2007).  
 
Besides the progress with respect to the molecular classification of the 
medulloblastoma, the cell of origin is another important topic of recent medulloblastoma 
research. In mice, the SHH-associated medulloblastomas may arise from CGNPs in 
the upper rhombic lip (Schüller et al. 2008) or cochlear granule neuron precursors 
(Grammel et al. 2012) and the Wnt-associated tumors may arise from pontine grey 
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neuronal progenitors within the lower rhombic lip and the dorsal brain stem (Gibson et 
al. 2010).  
 
Assuming that a medulloblastoma originates from immature neuronal cells, also the 
statistics of it reflects the fact that this is a typical embryonal tumor. The percentage of 
embryonal brain tumors including medulloblastomas compared to all primary brain 
tumors decreases from 15.1% in childhood (Ages 0-14) to 4.3% in adolescent (Ages 
15-19)  to 1.9% in adults (Ages 20-34) (CBTRUS 2012). 50% of all medulloblastomas 
occur in children under 5 years (Kaatsch et al. 2001). Furthermore, medulloblastomas 
have a strong tendency for dissemination through the cerebrospinal fluid in the 
leptomeningeal space (Gajjar et al. 2006; Wu et al. 2012). Therefore, the age of the 
patient at diagnosis, the dissemination of the primary tumor and the extent of residual 
disease after primary resection are important to make a statement about the prognosis 
and to determine which therapy is applied. Currently, this risk stratification and the 
subsequent therapies are more and more adapted to the molecular-based classification 
and the results of recent studies. Formerly, children under 3 years were considered as 
high risk patients with poor prognosis. In recent studies it was shown, that 65% of 
medulloblastomas in infants under 3 years of age are tumors of the SHH subgroup with 
predominantly desmoplastic histology (Northcott et al. 2011; Ramaswamy et al. 2011). 
Infants with a medullblastoma of this subgroup have good prognosis with postoperative 
chemotherapy alone (Ramaswamy et al. 2011; Rutkowski et al. 2005; von Bueren et al. 
2011). In contrast young children with a medulloblastoma of Group 3 have a very poor 
prognosis and respond poorly to current therapies (Northcott et al. 2011; Ramaswamy 
et al. 2011).       
In the standard therapy of medulloblastoma the aim of the surgical therapy is to resect 
the medulloblastoma totally, and in order to reduce the probability of a possible 
metastasis, the whole craniospinal axis is irradiated. In addition, a chemotherapy is 
performed (Roussel and Hatten 2011). The therapy can be adapted according to the 
risk of the patient. Despite enormous advances in diagnostics and therapies, the 5-year 
overall survival rate is still ~70% and surviving patients suffer from irreversible 
neurological and cognitive problems caused by the treatment. Therefore, it is important 
to improve therapies and develop more targeted therapies and molecular markers for 
diagnostics of medulloblastoma patients. One major advance in targeted therapies 
referring medulloblastomas was the discovery of the hedgehog-pathway inhibitor, 
called Vismodigib or GDC-0049, which is already included in a clinical study (Roussel 
and Robinson 2011; Rudin et al. 2009).  
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However, additional molecular targets for therapy and diagnostic markers are required. 
The role of β1-Integrin in medulloblastoma is unknown, but it displays an interesting 
candidate to fulfill this functions. Therefore the supporting facts for this assumption are 
summarized:  
A critical role of β1-Integrin was suggested for the development of the cerebrum and 
cerebellum and for the proliferation of CGNPs (Blaess et al. 2004; Graus-Porta et al. 
2001), which may give rise to medulloblastoma (Schüller et al. 2008).  
Apart from its role in developmental biology, β1-Integrin has a crucial role in 
tumorgenesis, what has been demonstrated most clearly through breast cancer 
research (Lahlou and Müller 2011; White et al. 2004; Yao et al. 2007).   
 
1.4. Aim of this study 
 
The first aim of this study is to specify the role of β1 Integrin in CGNPs and glial cells 
during cerebellar development.  
To clarify this, conditional knockout mouse models were used, where β1-Integrin was 
selectively inactivated once in CGNPs and once in glia cells.   
The second aim of this study is to investigate the role of β1-Integrin in the formation of 
medulloblastoma and if it could serve as a prognostic marker for medulloblastoma 
patients. Therefore, another conditional knockout mouse model was used to generate a 
Shh-associated medulloblastoma and delete conditionally β1-Integrin from these 
tumors. Since the Shh-associated medulloblastomas in this mouse model are derived 
from CGNPs (Schüller et al. 2008), additionally this experiment supports the first aim to 
specify the role of β1-Integrin in CGNPs. 
Furthermore, to learn more about the clinical relevance of β1-Integrin in 
medulloblastomas, the expression levels of ITGB1 (human β1-Integrin gene) was 
analyzed with relative, quantitative, real-time, reverse transcriptase (RT)–PCR in 
human medulloblastoma samples and this data were correlated with clinical 
parameters. 
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2. Material and Methods 
2.1. Mouse Lines, Genotyping, and Analysis of          
Recombination 
 
Itgb1Fl/Fl (Raghavan et al. 2000), SmoM2Fl/Fl (Mao et al. 2006), and hGFAP-cre 
mice (Zhuo et al. 2001) were obtained from The Jackson Laboratory (Bar Harbour, 
ME). 
 
2.1.1. Itgb1Fl/Fl mice 
 
A constitutive gene knockout of β1-Integrin in mice leads to a lethal phenotype, 
because of its essential relevance for the development (Fassler and Meyer 1995; 
Gaveriaux-Ruff and Kieffer 2007). To disrupt the function of β1-Integrin only in a 
special cellular compartment to a determined time, a Cre-LoxP system was used to 
generate conditional knockout mice. 
Therefore in the β1-Integrin gene, of the used mouse mode,l two LoxP sites are 
flanking Exon 3. This is called a floxed β1-Integrin gene (Figure 4). 
 
 
Figure 4 Schematic structure of the floxed segment within the β1-Integrin gene in mice obtained from 
Jackson Laboratory. Exon 3 flanked by LoxP sites (red triangles). The arrows represent the primers to 
detect the Cre-recombination. 
 
The loxP sites are short sequences of 34bps (base pairs) and show the Cre 
recombinase where to recombine. As a consequence of the recombination the gene 
segment between the two LoxP sites will be recombined and removed.  
The Cre-mediated recombination of the Itgb1 (mouse β1-Integrin gene) allele was 
analyzed by PCR using the following primers in a triple-primer procedure (Figure 4):  
Itgb1 Fw (Forward), 5’-CGCAGAACAATAGGTGCTGAAATTAC-3’,  
Itgb1 Rv (Reverse) 1, 5’-GCCCTGCTTGTATACATTCTCCG-3’,  
Itgb1 Rv 2, 5’-CCACAACTTTCCCAGTTAGCTCTC-3’. 
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2.1.2. Math1-cre mice 
 
The Cre recombinase is a tool used in targeted gene modification, it was first 
discovered and isolated from bacteriophage P1 (Sauer and Henderson 1988; 
Sternberg et al. 1981). The expression of the Cre recombinase is spaciotemporarily 
controlled by a promotor or an enhancer sequence (Gaveriaux-Ruff and Kieffer 2007). 
To specifically express the Cre recombinase in CGNPs, the 1.4kB upstream Math1 
enhancer element was used in the mouse model for this study (Matei et al. 2005; 
Schüller et al. 2007). The Itgb1Fl/Fl mice were crossed with Math1-cre mice to generate 
Math1-cre::Itgb1Fl/F and Math1-cre::Itgb1Fl/+  to delete β1-Integrin selectively in CGNPs. 
  
2.1.3. SmoM2Fl/Fl mice 
 
Smoothened (Smo) is a transmembrane protein of the Sonic hedgehog (Shh) signaling 
pathway. If the Sonic hedgehog pathway functions properly during developmental 
processes, the Sonic hedgehog protein binds to an extracellular domain of the Patched 
receptor and releases its inhibition of the Smoothened protein. This activation of 
Smoothened results in the expression of several genes (Ho and Scott 2002; Schüller et 
al. 2007), which are also responsible for the regulation of CGNPs and their proliferation 
in the EGL (Wechsler-Reya and Scott 1999)(Figure 5). 
 
 
Figure 5 ( modified from (Weinberg 2007)) The sonic hedgehog pathway. The Patched receptor (blue) is a 
transmembrane protein with 12 membrane-spanning domains and inhibits the Smoothened receptor 
(orange), a second transmembrane receptor spanning the membrane seven times. If the sonic hedgehog 
(Shh)(light green) protein binds to the extracellular domain of the Patched receptor, it will relieve the 
inhibition of Smoothened. Smoothened then sets in motion a intracellular signal cascade, including 
transcription factors to activate target genes of Sonic hedgehog for proliferation.  
 
If Smoothened carries a point mutation with the subsequent amino acid exchange 
W539L, the Smoothened protein and the sonic hedgehog pathway will be activated 
Patched Smoothened Sonic 
hedgehog 
Inactive Sonic hedgehog pathway Active Sonic hedgehog pathway 
plasma 
membrane 
activated signal 
cascade 
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autonomously and constitutive, this mutation is called the SmoM2 (Mao et al. 2006; Xie 
et al. 1998).   
A stop sequence, consisting of a polyadenylation casette (4xpA) is located upstream of 
SmoM2 to avoid ubiquitous expression of this oncogene. Additionally this stop 
sequence is floxed to remove it by a Cre recombinase and control the expression of 
SmoM2 conditionally (Figure 6). 
 
 
Figure 6 Simplified schematic structure of the SmoM2FL/FL gene, with a floxed STOP (red box) sequence, 
consisting of a polyadenylation cassette upstream of the SmoM2 (yellow box) oncogene. 
 
Itgb1Fl/Fl mice, Math1-cre mice and SmoM2Fl/Fl mice were crossed according to the 
following scheme in Figure 7 to receive the Math1-cre::SmoM2Fl/+ (control mice), 
Math1-cre::Itgb1Fl/Fl SmoM2Fl/+ and Math1-cre::Itgb1Fl/+SmoM2Fl/+ mice.  
 
 
Figure 7 Crossing scheme to receive Math1-cre::SmoM2Fl/+ (control mice), Math1-cre::Itgb1Fl/Fl SmoM2Fl/+ 
and Math1-cre::Itgb1Fl/+SmoM2Fl/+ mice. 
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For genotyping to proof the SmoM2 allel and the wild type allel the following primers 
were used:  
SmoM2 Fw, 5’- AAGTTCATCTGCACCACCG -3’;  
SmoM2 Rv, 5’-TCCTTGAAGAAGATGGTGCG -3’;  
Smo WT Fw, 5’-GGAGCGGGAGAAATGGATATG-3’;  
Smo WT Rv, 5’-CGTGATCTGCAACTCCAGTC -3’ (Jeong et al., 2004; Soriano, 1999).   
 
Mice suspected to develop a tumor according to their genotype with a Math1-cre plus a 
SmoM2 allele, were observed for neurological symptoms and general weakness twice 
a day. 
 
2.1.4. hGFAP-cre mice: 
 
The human glial fibrillary acidic protein (hGFAP) promotor sequence was used to 
control the expression of the Cre recombinase in glial cells of the transgenic mice in 
this study (Zhuo 2001). The genotyping for these mice was done with this primers: 
hGFAP-cre Fw 5’-ACTCCTTCATAAAGCCCTCG-3’,  
hGFAP-cre Rv 5’-ATCACTCGTTGCATCGACCG-3’ (Zhuo et al. 2001). hGFAP-cre 
mice were crossed with Itgb1Fl/Fl mice to generate hGFAP-cre::Itgb1 Fl/Fl and hGFAP-
cre::Itgb1Fl/+ mice. 
 
2.1.5. Genotyping of mice 
 
To identify the genotype of the mice aforementioned, a PCR was performed of genomic 
DNA extracted from mouse tail biopsies. 300 µl lyses buffer (100 mM Tris pH 8.5; 5 
mM EDTA pH 8.0, 0.2% SDS (filtered), 200 mM NaCl) and 10 µl of Proteinase K 
(10mg/ml) were added to the mouse tail. This solution digested the mouse tail for at 
least 2 hours at 55°C. After this time, the equal volume of UltraPure™ 
Phenol:Chloroform:Isoamyl Alcohol (25:24:1, v/v; from Invitrogen) was added and 
shaken for 15 minutes. Then this solution was fuged with 13.000 x g for 15 min at room 
temperature, to extract the top layer containing the DNA in a new tube. To precipitate 
the DNA, 50 µl 3 M sodium acetate (pH 5.2) and 1 ml of cold 95% ethanol were added. 
Than this solution was centrifugated with 13.000 x g at 4°C for 10 min. Liquid was 
discarded and the remaining liquid was removed with pipeman. The pellet was washed 
with 800 µl 70% Ethanol and mixed carefully and fuged another time with 13.000 x g at 
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4°C for 10 minutes. Then DNA pellet was dissolved in 100 µl DEPC 
(Diethylpyrocarbonate) water and stored at 4°C.  
 
2.2. Patients and Tumor Samples 
 
Overall, 37 surgical tumor samples from patients with medulloblastoma were analyzed. 
Patients included 22 males (58.5%) and 15 females (41.5%). They were treated at the 
University Hospital of Munich, Göttingen, Bremen, Hanover and Münster (all Germany). 
The majority of the patients with medulloblastoma were enrolled in the prospective 
multicenter trials of the German Society of Pediatric Hematology and Oncology. The 
median age of medulloblastoma patients was 7 years (range 0.7–39.7 years). The 
follow-up of survivors was 35.3 months (range 2.5–175.6 months). Up to the date of  
September 1st 2010, eleven of these patients succumbed the disease and 26 of them 
survived. The study included 1 anaplastic medulloblastoma, 22 medulloblastomas of 
classic histology, 10 medulloblastomas of desmoplastic histology, and 4 
medulloblastomas with extensive nodularity. Detailed patient characteristics are given 
in Table 1. The tumors were diagnosed by standard light microscopic examination of 
hematoxylin and eosin-stained sections and silver stains. In accordance with the WHO 
brain tumor classification (Louis et al. 2007) the tumors were diagnosed independently 
by at least two neuropathologists. Autopsy material of normal cerebella was obtained 
from patients, who gave their informed consent. Patient age ranged between 18 and 67 
years for adult cerebella, and between 22 weeks of gestation and 6 months for 
developing cerebella. None of these patients died from a central nervous system 
disorder or showed neuropathological abnormalities on histological examination.  All 
tissue samples were either immediately fixed in formaldehyde and embedded in 
paraffin or snap-frozen and stored at -80°C until use.  
18 
 
 
 
Table 1 : Clinical data of patients with medulloblastoma. DOD, Death of disease; NED, No evidence of 
disease. 
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2.3. RNA Extraction and Real-Time PCR 
 
Most cDNA probes of human medulloblastoma samples were obtained from Julia 
Pöschl, who extracted the RNA and performed reverse transcription according to the 
following protocols.  
To extract total RNA, 20-30 of 10 µm thick slices of snap frozen tissue were gently 
homogenized with the pipette in 750 µl of TRIzol® reagent (Invitrogen). Then this 
homogenized tissue was incubated at room temperature for 5 min, subsequently 150 µl 
of Chloroform were added and the suspension was shaken for 15 sec and another time 
incubated for 3 min at room temperature. Through centrifugation with 14.000 x g for 15 
min, the suspension was separated into three layers the undermost layer contained the 
DNA and TRIzol® reagent, the middle layer contained protein and cell detritus and the 
top layer contained RNA and Chloroform. The top layer (of approximately 350 µl) was 
transferred by pipette into a new tube. To precipitate the RNA, 375 µl of Isopropanol 
were added, and then it was briefly mixed, incubated for 10min at room temperature 
and afterwards fuged with 14.000 x g. The supernatant was discarded and the pellet 
was washed with 750 µl of Ethanol, then again the solution was centrifuged with 7.500 
x g at 4°C. The Ethanol was discarded and the rest was removed with the pipette. Then 
the RNA pellet was dissolved in 24 µl of DEPC water. To determine the concentration 
of the RNA in the solution, NanoDrop 3300 was used (Thermo Fisher Scientific). 
Subsequently total RNA was treated with RQ1 RNase-Free DNase (Promega), to 
remove the remaining DNA fragments. According to the protocol firstly the digestion 
reaction was prepared containing: 8 µl RNA (in DEPC water), 1 µl RQ1 RNase-Free 
DNase 10x Reaction Buffer, 1u RQ1 RNase-Free DNase was added per 1 µg of RNA. 
This solution was mixed and incubated at 37°C for 30 min, then 1 µl of RQ1 DNase 
Stop Solution was added to terminate the reaction. The following incubation at 65°C for 
10 minutes inactivated the DNase.  
SuperScript® II Reverse Transcriptase (Invitrogen) was used to run reverse 
transcription for human samples. Each reaction consisted of: Up to 4 µg total RNA in 
up to 8 µl, 1µl of 10 mM dNTP mix, mixture of 0.5 µl Oligo (dT)15 primers and 0.5 µl 
random hexamers (50 ng/µl), this solution was filled up to 10 µl with DEPC-treated 
water. The RNA/primer mixture was incubated at 65°C for 5 min then it was placed on 
ice for at least 1 min. In a different tube the 2x reaction mix; per run was prepared in 
the following order: 2 µl 10x RT Puffer, 4 µl 25m M MgCl2, 2 µl 0.1 M DTT, 1 µl 
RNaseOUTTM (40 U/µl) Recombinant Ribonuclease Inhibitor. 9 µl of this 2x reaction mix 
were added to each RNA/primer mixture and mixed gently, then it was incubated at 
room temperature for 2 min. To each tube 1 µl of SuperScript® II Reverse 
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Transcriptase was added and incubated at room temperature for 10 min, then it was 
incubated at 42°C for 50 min and the reaction was terminated at 70°C for 25 min and 
subsequently chilled on ice. Then the solution was collected briefly by centrifugation, 1 
µl of RNase H was added to each sample and incubated for 20 min at 37°C. Then the 
samples were stored at -20°C until their use for PCR. 
The real-time relative quantitative reverse transcriptase (RT)-PCR experiments were 
performed at the LightCycler® 480 (Roche) on 96 multiwell-plates with the 
LightCycler® 480 SYBR Green I Master reagents (Roche). When SYBR Green I dye 
binds to double-stranded DNA, the fluorescence signal of SYBR Green I dye in this 
complex increases significantly.  With progressive amplification of the specific DNA 
segment during PCR reaction also the fluorescence increases, which is measured after 
every cycle of PCR at the end of the elongation. 
The SYBR Green I Master Mix for LightCycler®480 included already a FastStart Taq 
DNA Polymerase and the SYBR Green I dye (Roche), from this mix 5 µl were used for 
each reaction. Furthermore it was added 1 µl Fw Primer and 1 µl of Rv Primer and 3µl 
of the cDNA. The LightCycler® 480 was programmed for PCR as follows: 
 
1. Incubation at 95°C for 5min 
2. Denaturation at 95°C for 10 seconds  
3. Annealing at 58°C for 10 seconds 
4. Elongation at 72°C for 15 seconds  
 
In this study the ITGB1 (human β1 Integrin) was the target gene, the aim was to 
measure the level of ITGB1 expression in tissue of human medulloblastoma. To 
perform relative quantification of the expression of the target gene Beta-2 
microglobuline was used as housekeeping gene, which is expressed constitutively in 
every sample and independent from pathological changes at the same level, . 
Additionally, every round of measurement the same calibrator sample was used to 
normalize the different rounds. Every measurement was done three times. The 
appropriate primers for this were found with Primer 3 software experiment. Sequences 
were as follows for the indicated genes:  
ITGB1 FW 5’-TGGGCTTTACGGAGGAAGTA-3’;  
ITGB1 RV 5’-CTACCAACACGCCCTTCATT-3’,  
B2M FW 5’-TGTCTTTCAGCAAGGACTGG-3’;  
B2M RV 5’- GATGCTGCTTACATGTATCG-3’.  
For each primer pair, melting curves were conducted after the amplification with 
LightCycler480® software and agarose gel electrophoresis were performed to 
These steps were repeated 45 
times 
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determine the presence of a single amplification product. To correct the efficiency for 
each set of primers, a standard curve was created. The efficiency of the B2M primer 
pair was 1.887 and for ITGB1 primer pair was 1.875.  
 
The calibrator normalized relative ratio was calculated the following way: 
 
Normalized Ratio=𝐸!!"# ! !!"#(!)x𝐸!!"# ! !!"#(!) 
 
CpT/CpR: Cycle number at target/reference detection threshold (crossing 
point); ET/ER: Efficiency of target/reference amplification; T: Target; R: 
Reference; S: Unknown sample; C: Calibrator 
 
2.4. Histology and Immunohistochemistry 
 
For all histological methods, brains were dissected, fixed overnight in 4% 
paraformaldehyd at 4°C, embedded in paraffin, and sectioned at 5 µm according to 
standard protocols. Hematoxylin and eosin (H&E) stains or Bielschowsky silver 
impregnations were performed according to standard protocols. For 
immunohistochemistry, paraffin sections were subjected to heat antigen retrieval at 
100°C for 20 min in 10 mM sodium citrate buffer for all antibodies. Staining was 
performed using the HRP/DAB staining system (DAKO) according to the 
manufacturer’s specifications. Primary antibodies were NeuN (Chemicon), Caspase3 
(Cell Signaling Technology), Ki67 (DAKO), PCNA (DAKO), phospho-Histone H3 
(pHH3, Cell Signaling Technology), Pax2 (Zymed), Pax6 (Developmental Studies 
Hybridoma Bank), Sox2 (Chemicon), Calbindin (Sigma), GFAP (DAKO), Cre 
recombinase (Covance), Zic1 (gift from R. Segal) and S100 (DAKO). All histological 
photomicrographs were taken digitally using an Olympus BX50 microscope in 
combination with the ColorView (Soft Imaging System).  
 
2.5. Western Blot analysis  
 
Proteins were extracted from tissue samples, lysis was performed on ice for 30 minutes 
in 500 µl of ice-cold lysis buffer containing 50 mmol/L Tris-HCl (pH 8), 120 mmol/L 
NaCl, 0.5% Nonidet® P-40 (Sigma), 1 mmol/L phenylmethyl sulfonyl fluoride (Sigma), 
100 U/ml aprotinin (Calbiochem), and 0.1 mol/L NaF. Debris was removed by 
centrifugation for 20 minutes at 12,000 x g and at 4°C (Hartmann et al. 2005). Samples 
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were separated by 10% sodium dodecylsulfate polyacrylamide gel electrophoresis and 
blotted on nitrocellulose. To document equal loading of the gels, Ponceau staining of 
the membranes was performed. Blocking was performed with 10% nonfat dry milk (Bio-
Rad) in Tris-buffered saline containing 0.05% Tween 20 and 20% horse serum for 2 
hours at room temperature. Subsequently, membranes were incubated with rabbit β1-
Integrin antiserum overnight (gift from Dr. Staffan Johansson, Uppsala University, 
Sweden). An alkaline phosphatase-coupled goat anti-rabbit antibody together with the 
CDP-Star solution (Roche) was used for detection. Quantifications were normalized to 
individual Actin levels for each sample. 
 
2.6. Statistical Analysis 
 
All obtained results were analyzed using the Prism4 software (Graph Pad). In vivo 
counting of phospho-histone H3-postive cells in the EGL was performed relating the 
total number of immunolabeled cells on each section to the overall length of the EGL. 
Results derived from counting three different sections of two animals for each 
genotype. Survival of patients and mice was analyzed using Kaplan–Meier survival 
curves and the Log-rank test was used to examine the significance of results. P-values 
< 0.05 were considered as significant. The unpaired t-test was applied to compare the 
means of two groups with assumed Gaussian distribution and equal variances. If 
variances were not equal, as confined by the F-test, or Gaussian distribution was not 
expected, the nonparametric Mann–Whitney test for unpaired data was used to 
compare the medians of two groups. For quantification of immunohistochemical 
reactivity for S100 and Cre in the Purkinje cell layer (PCL) and the molecular layer 
(ML), positive cells in lobules III and V were counted in three sagittal cerebellar 
sections per mouse for three different animals per genotype. The PCL was defined as 
the area from 5 µm below the bottom to 5 µm above the top of Purkinje cell somata. 
The number of immunoreactive cells was counted separately and expressed as cells 
per mm PCL.  
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3. Results 
3.1. Expression of β1-Integrins in Cerebellar Granule Neuron 
Precursors  
 
β1-Integrins in Nestin-positive precursors were previously found to regulate the 
formation of cortical structures in the brain (Graus-Porta et al. 2001).  The deletion of 
β1-Integrin in Nestin-positive neural precursors in conditional knockout mice results in a 
decrease in size and perturbed cortical lamination of the cerebellum. It should be 
mentioned that Nestin is expressed in all kinds of neural precursors. To address the 
specific role of β1-Integrins in CGNPs for the formation of the cerebellar cortex, the 
Itgb1 gene was conditionally inactivated by using a Math1-cre line, which is known to 
recombine CGNPs, but no other cell types of the cerebellar cortex (Machold and Fishell 
2005; Schüller et al. 2007; Wang et al. 2005). In a first step, it was analyzed whether 
β1-Integrins have indeed been deleted from CGNPs in this mouse model.  Therefore 
genomic DNA from the EGL of paraffin sections was isolated and checked for the 
recombination of the Itgb1 allele by semiquantitative PCR. As expected, the Itgb1 allele 
has been recombined in the majority of cells in the EGL (Figure 8 A).  
Furthermore, Western blot analysis of cerebellar tissue from Math1-cre::Itgb1Fl/Fl mice 
isolated at P7 revealed a reduction of almost 50% in β1-Integrin protein levels (Figure 8 
B).  
Bearing in mind whole cerebellum lysates which also contained Math1-negative cell 
types were used, it was reasoned that β1-Integrins have been deleted in the majority of 
Math1-cre::Itgb1Fl/Fl CGNPs. 
 
Figure 8 Inactivation of β1-Integrins in CGNPs of the cerebellum. PCR analysis of genomic DNA isolated 
from the external granule layer of wild type, Itgb1Fl/Fl and Math1-cre::Itgb1Fl/Fl mice at postnatal day 7 (P7) 
indicating the different Itgb1 alleles (A). Western blot analysis for β1-Integrins in cerebella of indicated 
genotypes confirmed deletion of β1-Integrins in Math1-cre::Itgb1Fl/Fl mice (B). 
 
To investigate the effect of β1-Integrin deletion in CGNPs, Hematoxylin and Eosin-
stained sagittal sections were assessed of postnatal day 7 (P7) and adult  
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Math1-cre::Itgb1Fl/Fl mice to analyze the overall organization of the cerebellar cortex. As 
in Itgb1Fl/Fl mice that do not express Cre recombinase in CGNPs, cortical layers of the 
cerebellum in Math1-cre::Itgb1Fl/Fl mice appeared normal during development and at 
the adult stage (Fig. 9 A,B,D,E,G,H,J,K).  
Immunohistochemical staining using antibodies against NeuN, a postmitotic neuronal 
marker, revealed that the differentiation of CGNPs into mature cerebellar granule 
neurons remained unaffected in Math1-cre::Itgb1Fl/Fl mice (Fig. 9 C,F,I,L).  Furthermore, 
Caspase3 immunoreactivity displayed no differences with respect to the apoptotic 
activity in cerebella of Itgb1Fl/Fl and Math1-cre::Itgb1Fl/Fl mice at P7 (Fig. 9 M,Q). In both 
control and conditional knockout mice, only few apoptotic cells were visible, 
predominantly in the IGL and the prospective white matter. It has previously been 
proposed that β1-Integrins are essential for the proliferation and the ongoing expansion 
of the CGNP pool during development (Blaess et al. 2004). To address whether the 
deletion of β1-Integrins in CGNPs in vivo caused any proliferative defects that would 
not be visible on standard histology, the number of proliferating cells in the EGL at P7 
was analyzed. This age was chosen, since it represents the phase of highest CGNP 
proliferation during cerebellar development (Wechsler-Reya and Scott 1999). However, 
immunostaining for proliferation markers such as Ki67 and proliferating cell nuclear 
antigen (PCNA) revealed no differences between Math1-cre::Itgb1Fl/Fl and Itgb1Fl/Fl mice 
(Fig. 9 N,R,O,S). Further antibodies against phosphorylated histone H3 (pHH3), 
expression of which marks cells in the M phase of the cell cycle, were used and 
analyzed its expression in the cerebellar EGL (Figure 9 P,T). Cell counts in histological 
sections confirmed that the EGL of Math1-cre::Itgb1Fl/Fl mice contained normal numbers 
of mitotic cells (Figure 9 U). In addition to that, primary cultured and Cre-IRES-GFP 
virus-transduced CGNPs from postnatal day 7 Itgb1Fl/Fl mice revealed no statistically 
significant differences with respect to BrdU-incorporation as compared with control 
cells that were transduced with IRES-GFP virus (Figure 9 V, this experiment was 
performed by Pierfranesco Pagella). Thus, the acute deletion of β1-Integrins in CGNPs 
did not affect their proliferative activity in response to Sonic hedgehog. Taken together, 
the conclusion is that the expression of β1-Integrins in CGNPs is not required for the 
proper formation of the murine cerebellum. 
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Figure 9 Inactivation of β1-Integrins in CGNPs of the cerebellum. Histological analysis of cerebella from 
Itgb1Fl/Fl and Math1-cre::Itgb1Fl/Fl mice did not show any differences at P7 or adult stages (C–T). Paraffin-
embedded sections were stained with Hematoxylin-Eosin or antibodies specific for neuronal nuclei protein 
(NeuN), Caspase3, Ki67, proliferating cell nuclear antigen (PCNA), and phospho-Histone H3 (pHH3). 
Statistical analysis of pHH3-positive cells in the external granule layer of Itgb1Fl/Fl and Math1-cre::Itgb1Fl/Fl 
mice revealed no differences in proliferation (U). Acute deletion of β1-Integrins by Cre virus in cultured 
CGNPs of Itgb1Fl/Fl mice had no effect on proliferative activity in response to Sonic hedgehog (V this 
experiment was performed by Pierfrancesco Pagella). Boxed areas in A, D, G, and J are shown as higher 
magnifications in adjacent pictures. EGL, external granular layer; IGL, internal granular layer; ML, 
molecular layer; PCL,Purkinje cell layer; WM, white matter; n. s., not significant. Scale bars: 500 µm (in A 
for A, F; in G for G, J), 25 µm (in B for B, C, E, F, H, I, K-T). 
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3.2. Expression of β1-Integrin in Shh-induced mouse 
medulloblastoma and human medulloblastoma 
 
Medulloblastoma, the most common malignant brain tumor in childhood, can be divided 
into four different subgroups depending on their gene expression profile and there is 
evidence that subtypes of medulloblastoma have distinct developmental origins 
(Gibson et al. 2010; Taylor et al. 2012). Medulloblastoma with activated Wnt pathway 
may arise outside of the cerebellum from cells of the dorsal brainstem (Gibson et al. 
2010), whereas Shh-associated tumors are suggested to arise from the CGNP 
population of the cerebellum (Schüller et al. 2008). Given the previously reported 
importance of β1-Integrins in tumorigenesis and cerebellar development (Graus-Porta 
et al. 2001; White et al. 2004), β1-Integrin subunit was conditionally deleted from 
tumors in Math1-cre::SmoM2Fl/+ mice that served as a model for CGNP-derived 
medulloblastoma (Schüller et al. 2008). In such mice with a Math1-
cre::Itgb1Fl/FlSmoM2Fl/+ genotype, Cre expression driven by Math1 promoter sequences 
was supposed to delete β1-Integrins in CGNPs, while the Shh pathway is constitutively 
activated through the oncogenic SmoM2 mutation that is expressed under control of 
the same promoter. To estimate whether the deletion of β1-Integrins had substantial 
impact on the survival of Math1-cre::SmoM2Fl/+, a Kaplan–Meier analysis was first 
performed to compare the survival of Math1-cre::SmoM2Fl/+ (n = 21), Math1-
cre::Itgb1Fl/+SmoM2Fl/+ (n = 16), and Math1-cre::Itgb1Fl/FlSmoM2Fl/+ mice (n = 40). 
However, there were not detected any statistically significant differences in the overall 
survival of these mice (Figure 10 A). PCR analysis from DNA of tumor tissue confirmed 
that the Itgb1 allele had successfully been recombined both in Math1-
cre::Itgb1Fl/+SmoM2Fl/+ and in Math1-cre::Itgb1Fl/FlSmoM2Fl/+ mice (Figure 10 B). 
Moreover, protein levels of β1-Integrins were clearly reduced in tumors of Math1-
cre::Itgb1Fl/+SmoM2Fl/+ mice and almost absent in tumors of Math1-cre::Itgb1Fl/Fl 
SmoM2Fl/+ mice (Figure 10 C). Histological analysis of the tumors did not reveal any 
differences in Math1-cre::Itgb1Fl/+SmoM2Fl/+ or Math1-cre::Itgb1Fl/FlSmoM2Fl/+ mice as 
compared with control mice with respect to overall morphology and immunoreactivity 
for Ki67 (Figure 10 D–L). Quantification of the proliferative activity did not reveal any 
significant differences between the indicated genotypes (Figure 10 M). 
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Figure 10 Analysis of Itgb1 in medulloblastoma. Kaplan–Meier curves for mice of the three indicated 
genotypes revealed no statistically significant differences in survival (A). Semiquantitative PCR analysis of 
DNA from murine medulloblastoma confirmed the successful recombination of the Itgb1 allele (B). 
Expression levels of βIntegrin1-Integrin protein in indicated medulloblastoma tissues confirmed β1-integrin 
deletion in Math1-cre::Itgb1Fl/FlSmoM2Fl/+ mice (C). Histology with low and high magnification and 
expression of Ki67 visualized by immunohistochemistry of Math1-cre::SmoM2Fl/+, Math1-
cre::Itgb1Fl/+SmoM2Fl/+, and Math1-cre::Itgb1Fl/FlSmoM2Fl/+ mice showed no differences (D–M). Relative 
expression of ITGB1 in human developing cerebellum (DCB), adult cerebellum (ACB), desmoplastic 
medulloblastoma (DMB), and classic medulloblastoma (CMB) revealed high expression of ITGB1 in 
medulloblastomas and developing cerebella in comparison to adult cerebella (N). No statistically significant 
differences between the histological subtypes, CMB and DMB, were noted with respect to ITGB1 
expression. Overall survival rates of medulloblastoma patients (n = 37) grouped according to those with 
expression levels of ITGB1 below the median and above the median were similar (P 5 0.2, O). MB, 
medulloblastoma; BS, brainstem; n. s., not significant. Scale bars: 3 mm (in D for D, G, J); 50 µm (in E for 
E, F, H, I, K, L). 
M 
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Last, the β1-Integrin-deficient tumors displayed normal expression with regard to Zic1 
that labels cerebellar granule neurons and granule neuron-derived medulloblastomas 
(Figure 11 A–D).  
 
Figure 11 Expression of Zic1, a marker of neuronal differentiation, in Itgb1-deficient and control 
medulloblastoma of mice with the indicated genotype. Expression of Zic1 (A-C) show no differences in 
medulloblastoma from indicated mouse models. Quantification for Zic1-positive cells in medulloblastomas 
from Math1-cre::SmoM2Fl/+, Math1-cre::Itgb1Fl/+SmoM2Fl/+ and Math1-cre::Itgb1Fl/FlSmoM2Fl/+ mice (D). 
Scale bars: 50 µm. 
 
Since the mouse model of Shh-associated medulloblastoma used for this study, did 
most likely not fully reflect the situation in all molecular subtypes of human 
medulloblastoma, real-time RT-PCR was used to analyze the relative expression of 
human Integrin β1 gene (ITGB1) in human samples of normal cerebella (n = 8) and 
medulloblastoma (n = 37) and subsequently its correlation with the patients’ survival 
was investigated. 
In comparison to adult cerebella, ITGB1 was highly expressed during development and 
in medulloblastomas (P = 0.03 and P = 0.04, respectively, Figure 12). However, there 
was no significant difference in ITGB1 expression between desmoplastic (n = 10) and 
classic (n = 22) medulloblastomas, the two major histological tumor subtypes (P = 0.13, 
Figure 12).  
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Figure 12 Relative expression of ITGB1 in human developing cerebellum (DCB), adult cerebellum (ACB), 
desmoplastic medulloblastoma DMB), and classic medulloblastoma (CMB) revealed high expression of 
ITGB1 in medulloblastomas and developing cerebella in comparison to adult cerebella. No statistically 
significant differences between the histological subtypes, CMB and DMB, were noted with respect to 
ITGB1 expression. 
 
To further support this finding, publicly available microarray data from an independent 
series of 62 medulloblastoma samples were reanalyzed (Kool et al. 2008) with regard 
to the ITGB1 expression in different molecular subtypes of medulloblastoma. Molecular 
subtyping of medulloblastomas was performed according to a recent consensus that 
defined four main subtypes (Taylor et al. 2012). According to this data, ITGB1 was 
expressed in all molecular subtypes of medulloblastoma, and there was no statistically 
significant difference regarding its expression levels (Figure 13). 
 
Figure 13 Relative expression of ITGB1 in molecular subtypes of medulloblastoma molecular subgroups 
(Kool et al. 2008; Taylor et al. 2012). ITGB1 is expressed in all molecular subtypes of medulloblastoma, 
but there is no statistically significant difference between the different subtypes regarding ITGB1. 
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Next, the survival of patients was analyzed according to the mRNA levels of ITGB1. 
For Kaplan–Meier analyses, patients were divided in two groups based on the median 
ITGB1 expression of their tumors. As shown in Figure 14, the expression of ITGB1 was 
not correlated with the patient’s survival (P = 0.2). The conclusion of these results is 
that the expression of β1-Integrins in CGNPs was not essential for the formation of 
CGNP-derived medulloblastoma and had no impact on the survival of tumor-prone 
mice. Furthermore, β1-Integrins were highly expressed in human medulloblastomas, 
but their expression had no prognostic role in medulloblastoma patients. 
 
 
Figure 14 Overall survival rates of medulloblastoma patients (n = 37) grouped according to those with 
expression levels of ITGB1 below the median and above the median were similar (P = 0.2). n. s.; not 
significant. 
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3.3. Expression of β1-Integrins in Glia of the cerebellum 
 
Although conditional deletion of β1-Integrins under the control of Nestin promoter 
sequences had severe consequences for the development of the cerebellum, deletion 
of β1-Integrins in committed cerebellar granule neurons that express Math1 did not 
affect cerebellar development or tumorgenesis. To further investigate, which cell types 
within the cerebellar cortex would require β1-Integrins for appropriate development, a 
hGFAP-cre mouse line was used for driving Cre-mediated deletion of β1-Integrins in 
glia of the postnatal cerebellum (Malatesta et al. 2003; Zhuo et al. 2001). Hematoxylin 
and Eosin-stained sections from 7-day-old hGFAPcre::Itgb1Fl/Fl mice revealed cerebella 
that were clearly smaller than those from hGFAP-cre:Itgb1Fl/+ control mice (Figure 15 
A,D). The depth of fissures as well as the size of individual lobules were decreased, 
and cerebellar lobules of hGFAP-cre::Itgb1Fl/Fl mice were fused together (Figure 15 
B,C,E,F; arrow in F points to the fusion line of two adjacent lobules). In adult mutant 
cerebella, the overall size was still reduced and no clear fissures formed between 
adjoining lobules (Figure 15 G–L). The internal granular layer (IGL) was less prominent 
in size and displayed a rather washed-out and less confined structure. Moreover, some 
cerebellar granule neurons formed ectopia along the fusion line of adjacent lobules and 
on the cerebellar surface of hGFAP-cre::Itgb1Fl/Fl mice (Figure 15 I,L; arrow in L points 
toward cerebellar granule neurons ectopia on the fusion line of adjacent folia). To 
visualize the nerve fiber organization in the cerebellar cortex, a Bielschowsky silver 
impregnation was performed on cerebellar sections of hGFAPcre:: Itgb1Fl/Fl and control 
mice (Figure 15 M,N). Parallel fibers of the cerebellum of hGFAP-cre::Itgb1Fl/Fl mice 
appeared extenuated in terms of size and number as compared with control mice. 
Furthermore, parallel fibers did not display their natural orientation parallel to the 
cerebellar surface. They were arranged in a rather disoriented fashion throughout the 
ML (Figure 15 N). Taken together, the cerebellum of hGFAP-cre::Itgb1Fl/Fl mice was 
severely affected in terms of size, cortical lamination, and nerve fiber organization.  
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Figure 15 Cerebellar histology in hGFAP-cre::Itgb1Fl/+ and hGFAPcre::Itgb1Fl/Fl mice. Cerebella were 
analyzed at postnatal day 7 (P7, A–F) and adult stage (G–P). Paraffin sections were stained with 
Hematoxylin-Eosin (H&E). Boxed areas are shown as higher magnifications in adjacent pictures. Arrows in 
(F) and (L) point to remnants of the external granule layer. Bielschowsky silver impregnation of nerve 
fibers reveals a gross disorganization of parallel fibers in the molecular layer of hGFAP-cre::Itgb1Fl/Fl mice 
(M, N).). EGL, external granule layer; IGL, internal granule layer; ML, molecular layer; PCL Purkinje cell 
layer. Scale bars: 2 mm (in A for A, D, G, J); 200 µm (in B for B, E, H, K); 100 µm (in C for C, F, I, L); 10 
µm (M, N). 
 
To further characterize the above described phenotype, immunohistochemistry was 
performed for several cellular markers on P7 and adult cerebella that were able to 
identify major neuronal cell types. Islands of ectopic cells that were stuck on the 
cerebellar surface were strongly positive for NeuN and Pax6, as early as P7 (Figure 16 
A,B,F,G,K,L,P,Q), arguing that these cells are cerebellar granule neurons (Weyer and 
Schilling 2003) that were not able to migrate into the inner granule layer and 
prematurely differentiated in this position. Antibodies against Pax2 and Calbindin were 
then used to identify inhibitory interneurons and Purkinje neurons, respectively (Figure 
16 C,D,H,I,M,N,R,S). Pax2-positive as well as Calbindin-positive cells were regularly 
detected in cerebella of P7 and adult hGFAP-cre::Itgb1Fl/Fl mice, suggesting that these 
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cell populations were properly specified and remained unaffected. Finally, expression 
of Ki67 revealed a normal proliferative activity in hGFAPcre::Itgb1Fl/Fl mice (Figure 16 
E,J,O,T). However that cerebellar granule neuron ectopia did not proliferate, further 
supporting the hypothesis that these are mature cerebellar granule neurons. It is well 
known that cerebellar granule neurons of the external granular layer of the cerebellum 
migrate along Bergmann glial fibers into the inner granular layer (Hatten 2002).  
 
 
Figure 16 Analysis of different cell types in hGFAP-cre::Itgb1Fl/Fl mice compared with controls. 
Immunohistochemistry using indicated antibodies was performed on sections of paraffin-embedded 
cerebella from hGFAP-cre::Itgb1Fl/+ (control) and hGFAP-cre::Itgb1Fl/Fl mice at postnatal day 7 (P7, A–J) 
and adult stage (K–T) to visualize the major cell types and proliferative activity in the cerebellar cortex. 
Dashed lines delineate the surface of the cerebellum between two cerebellar lobes. Scale bars: 50 µm (in 
A for A-T). 
 
In this context, it was aimed to examine if the observed migration defect of cerebellar 
granule neurons in hGFAPcre::Itgb1Fl/Fl mice might be attributed alterations in the 
Bergmann glia cell population. To test this, the expression of different Bergmann glia 
markers was analyzed in the ML and the PCL. Whereas GFAP immunoreactivity in P7 
cerebella was hardly detectable (Figure 17 A,E), the GFAP signal in adult hGFAP-
cre::Itgb1Fl/Fl mice revealed that radial glial fibers extending from Bergmann glia showed 
no directional outgrowth to the cerebellar surface as compared with control mice and 
terminated randomly within the ML (Figure 17 I,M). The expression of Sox2 was 
restricted to Bergmann glia within the PCL in control mice according to the literature 
(Figure 17 B,J) (Sottile et al. 2006), but Sox2 expressing cells were found in the PCL, 
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the ML, and cerebellar granule neuron ectopia of hGFAP-cre::Itgb1Fl/Fl mice (Figure 17 
F,N). To visualize Bergmann glia cells during postnatal development, the expression of 
S100 protein was also analyzed in the cerebellum of hGFAP-cre::Itgb1Fl/Fl mice. The 
vast majority of Bergmann glia cells inhabited the PCL in P7 and adult cerebella of 
control mice. Only few positive cells were detected in the ML or the IGL (Figure 17 
C,K). In contrast, S100-positive cells invaded the ML and cerebellar granule neuron 
ectopia on the cerebellar surface of hGFAPcre::Itgb1Fl/Fl mice (Figure 17 G,O), further 
indicating a disorganization of the glial network. Last, antibodies against Cre were used 
that served as a surrogate marker of hGFAP in this system. Although Cre expressing 
cells in P7 control mice inhabited the PCL, the IGL, and the white matter (Figure 17 D), 
Cre expressing cells in P7 hGFAP-cre::Itgb1Fl/Fl mice were also detected in the ML, the 
EGL, or in ectopic cerebellar granule neuron accumulations (Figure 17 H). In the adult 
control cerebellar cortex, Cre immunoreactivity was only seen in Bergmann glia of the 
PCL (Figure 17 L), while in hGFAP-cre::Itgb1Fl/Fl mice Cre expressing cells were visible 
in the PCL and in the ML (Figure 17 P). 
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Figure 17 Translocation of Bergmann glia cells into the molecular layer in hGFAP-cre::Itgb1Fl/Fl mice. 
Cells positive for astrocytic markers hGFAP, Sox2, and S100 as well as Cre were predominantly localized 
in the Purkinje cell layer (PCL) of control mice, while a number of cells expressing these markers was 
distributed throughout the molecular layer (ML) in hGFAP-cre::Itgb1Fl/Fl mice both at postnatal day 7 as well 
as at adult stages (A–P). Scale bars: 25 µm (in A for A-P); 10 µm (inset in B; for all insets). 
 
To further substantiate these findings, the number of cells was quantified in both the 
PCL and the ML that expressed S100 and Cre (Figure 18 A, B). The number of S100-
positive cells in the PCL significantly decreased in hGFAP-cre::Itgb1Fl/Fl mice as 
compared with controls, while S100-positive cells in the ML markedly increased (Figure 
18 A). At the same time, the overall number of S100-positive cells was not changed, 
indicating that Bergmann glia cells translocate from the PCL to the ML in hGFAP-
cre::Itgb1Fl/Fl mice. These data are supported by quantification of Cre expressing cells 
in hGFAPcre::Itgb1Fl/Fl and control mice (Figure 18 B). 
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Figure 18 Quantification of S100- and Cre-positive cells in the PCL and ML at adult stage revealed that 
Bergmann glia cells translocate into the ML, while the overall number of Bergmann glia cells is not 
changed (A, B ). 
The conclusion is that loss of β1-Integrins in cerebellar glia has dramatic impact on the 
development of multiple cortical cell types. Although radial glia revealed pathological 
positioning and inappropriate development of its processes, cerebellar granule neurons 
were prohibited from physiological migration and underwent premature differentiation in 
ectopic regions of the superficial cerebellar cortex. 
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4. Discussion 
 
In this study, β1-Integrin was inactivated selectively in granule neuron precursors of the 
cerebellum and in glia. Although the loss of β1-Integrins in glia has previously been 
described to result in reactive gliosis and in an activation of microglial cells in the 
forebrain (Robel et al., 2009), its role during cerebellar development was unclear, 
particularly with respect to glial-neuronal interactions. It was demonstrated that the loss 
of β1-Integrins in CGNPs did not affect the overall cerebellar development. In contrast, 
the deletion of β1-Integrins in glia resulted in severe malformations of the cerebellum, 
including the fusion of cerebellar folia and a disturbed migration of CGNPs. It should be 
mentioned that hGFAP promoter sequences do not provide a Bergmann glia-specific 
way to drive Cre expression and consecutively delete β1-Integrin. In fact, hGFAP-cre is 
similarly fate-mapping granule neurons and astrocytes of the cerebellum (Zhuo et al. 
2001). Although, it cannot be totally ruled out the contributions of other affected cell 
types to the phenotype observed in hGFAP-cre:Itgb1Fl/Fl mice, the results of this study 
suggest that the deletion of β1-Integrins in Bergmann glia is responsible for the 
observed malformations for the following reasons: First, Math1-cre-driven β1-Integrin 
knockout in granule neurons alone did not result in any cerebellar pathology. Second, 
the observed migratory deficit of cerebellar granule neuron progenitors points to the 
Bergmann glia cells as the primary cause of the phenotype (Rakic and Sidman 1973). 
Third, massive morphological abnormalities were detected within the Bergmann glia 
cell population. The described impairment of cerebellar lamination in hGFAP-
cre:Itgb1Fl/Fl mice is in line with previous findings that described the deletion of β1-
Integrins in early neural precursor populations using the Nestin promoter (Graus et al., 
2001). Here, it had been proposed that β1-Integrins in glial cells are required for the 
anchorage of glial endfeet to the meningeal basement membrane and the overall 
assembly of the basement membrane. Glial network perturbations near the basement 
membrane were also described to be responsible for cerebellar granule neuron ectopia 
(Graus et al., 2001). In contrast, it has been proposed that β1-Integrins act at least in 
part cell autonomously in CGNPs to positively regulate the synergistic effect of laminin 
on Shh-induced proliferation (Blaess et al., 2004). Although Blaess et al. used primary 
CGNPs cultures from Nestin-cre:Itgb1Fl/Fl mice and mainly tested the interaction of β1-
Integrins and laminin in the context of Shh-induced proliferation, in this study 
conditional knockout mice with a specific Itgb1 knockout in granule neuron precursors 
were  investigated, but it was not possible to find any impact of β1-Integrin expression 
in granule neurons. In fact, the in vivo results suggest that β1-Integrin expression in 
Math1-positive cerebellar granule neurons, which represent the majority, if not all 
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granule neurons, is dispensable for the development of the cerebellum. To exclude 
compensatory mechanisms that could take place in vivo and possibly obscure essential 
roles of β1-Integrin, Pierfrancesco Pagella performed experiments, where he acutely 
deleted β1-Integrin in primary cultured Itgb1Fl/Fl CGNPs by Cre/loxP-based 
recombination, but he did not detect any effects on Shh associated proliferation (Frick 
et al. 2012). The above mentioned results are supported by previous findings, which 
demonstrated that the deletion of β1-Integrins in migrating neurons is not sufficient to 
disturb the formation of cell layers in the cerebral cortex and the morphological 
differentiation of cortical neurons (Belvindrah et al., 2007). Furthermore, in vitro 
experiments on cerebellar CGNPs using inhibitory antibodies against β1-Integrins did 
not reveal any impact on BrdU-incorporation (Le Dreau et al. 2010). Instead, Daniel 
Grammel demonstrated in his in vitro experiments that the deletion of β1-Integrins from 
radial glia abolishes the poly-L-ornithine/laminin-mediated extension of glial fibers, 
which subsequently results in an impairment of CGNP development (Frick et al. 2012). 
It appears possible that redundant receptor systems partly compensate the loss of β1-
Integrins in vivo since the glial fiber system and neuronal migration in the cerebellum of 
hGFAP-cre::Itgb1Fl/Fl mice was only partly disturbed. Nevertheless, the data of this 
study suggest that all development changes seen in Nestin-cre:Itgb1Fl/Fl mice (Graus et 
al., 2001) are caused by the loss of β1-Integrins in glia, but not in cerebellar granule 
neurons. Interestingly, the size of hGFAP-cre::Itgb1Fl/Fl cerebella was significantly 
smaller when compared with controls, a phenomenon that could point toward major 
defects in the proliferation of cerebellar granule neurons. However, it can be argued 
that these proliferation defects are not due to granule cell-autonomous functions of β1-
Integrins and that any impairment in granule neuron proliferation may be a secondary 
phenomenon due to inappropriate migration along β1-Integrin-deleted radial glia. This 
hypothesis is supported by a previous report, where inappropriate development of 
Bergmann glia secondarily leads to a marked reduction of CGNP proliferation (Hoser et 
al. 2007). β1-Integrins have been studied intensively in various cancer types. Several 
reports indicate that β1-Integrins facilitate tumor progression in breast carcinoma 
(Chung et al. 2004; Friedrichs et al. 1995; Weaver et al. 1997; Wewer et al. 1997; Yao 
et al. 2007). Furthermore, β1-Integrins have been implicated in other cancer types such 
as prostate or colorectal cancer (Fujita et al. 1995; Rabinovitz et al. 1995), and have 
shown to serve as a prognostic marker in gastric and breast cancer (Xu et al. 2010; 
Yao et al. 2007). However, conflicting data attribute β1-Integrins a tumor suppressor 
function in breast cancer or tumor formation in the skin (Owens and Watt 2001; Zutter 
et al. 1995). This study demonstrates that deletion of β1-Integrin from tumors that arise 
in a mouse model of CGNP-derived medulloblastoma did not result in a significant 
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survival benefit. This observation is in line with the results from Math1-cre::Itgb1Fl/Fl 
mice, where β1-Integrins are dispensable for the proper development and proliferation 
of CGNPs. Furthermore, mRNA expression levels of β1-Integrin in human 
medulloblastoma samples did not predict patient outcome and thus appear not to have 
a prognostic value in medulloblastoma. Therefore, high expression of β1-Integrins in 
human medulloblastoma samples rather reflects overall genetic setup of cancer cells 
and similarities to immature, proliferating CGNPs than highlighting a special role of β1-
Integrins in the formation of this tumor type. This situation is different from what has 
been shown for other tumors such as breast cancer, and it may also be different in 
gliomas that are frequent brain tumors, most likely arising from glial precursor cells. 
Here, it has been attributed a considerable role of α6β1-Integrin in tumor progression 
(Delamarre et al. 2009), and it is tempting to speculate whether loss of β1-Integrins 
may result in reduced growth of glioma or enhanced survival. 
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5. Summary 
5.1. Summary 
 
β1-class Integrins play essential roles both in developmental as well as in cancer 
biology. Particularly, a Nestin-driven deletion of β1-Integrin receptors results in severe 
abnormalities of brain development including a laminar disorganization of cerebellar 
granule neurons. However, since Nestin is expressed in all kinds of neural precursors, 
these data do not allow conclusions to be drawn about the role of β1-Integrins in 
distinct neuronal and glial cell types. By generating conditional knockout mice using 
granule neuron specific Math1-promoter sequences, it is shown that the expression of 
β1-Integrins in cerebellar granule neurons is dispensable for the development of the 
cerebellum. In another conditional knockout mouse model, the deletion of β1-Integrin in 
medulloblastomas that are derived from cerebellar granule neuron precursor (CGNP) 
did not result in a significant survival benefit. Last, the prognosis of the patient cannot 
be predicted by the expression of β1-Integrin in human medulloblastoma samples. 
However, a β1-Integrin knockout using hGFAP-promoter sequences led to cerebellar 
hypoplasia, misplacement of Bergmann glia in the molecular layer, undirected 
outgrowth of radial glial fibers, and cerebellar granule neuron ectopia. The conclusion 
of this data is that the expression of β1-Integrin in cerebellar granule neurons is not 
important during its development or the formation of medulloblastoma. In fact, it is the 
expression of β1-Integrin in glia that is crucial for the proper development of the 
cerebellar cortex.  
 
5.2. Zusammenfassung 
 
Integrine der Klasse β1 spielen sowohl in der Entwicklungs- als auch in der 
Tumorbiologie eine wichtige Rolle. Insbesondere eine Nestin-gesteuerte Entfernung 
von β1-Integrin-Rezeptoren führt zu schweren Abnormalitäten der Gehirnentwicklung, 
einschließlich einer laminären Fehlorganisation von zerebellären Körnerzellneuronen. 
Jedoch wird Nestin in allen Typen von neuralen Vorläuferzellen exprimiert, deshalb 
können aus diesen Daten keine Rückschlüsse auf die Rolle von β1-Integrinen in 
einzelnen neuronalen und glialen Zelltypen gezogen werden. Durch die Erzeugung 
konditioneller Knockout-Mäuse, unter der Verwendung einer für Körnerzellneuronen 
spezifischen Math1-Promotorsequenz, wird gezeigt, dass die Expression von β1-
Integrin in zerebellären Körnerzellneuronen für die Entwicklung des Kleinhirns 
entbehrlich ist. In einem weiteren konditionellen Knockout Mausmodell führt die 
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Eliminierung von β1-Integrin in Medulloblastomen, die aus Vorläufern zerebellärer 
Körnerzellneuronen hervorgehen, zu keinem signifikanten Überlebensvorteil. Zuletzt, 
kann die Prognose des Patienten nicht durch die Expression von β1-Integrin in 
humanen Medulloblastomproben vorhergesagt werden. Ein Knockout von β1-Integrin 
unter Steuerung von hGFAP-Promotorsequenzen führt allerdings zur 
Kleinhirnhypoplasie, zur falschen Lage der Bergmann Gliazellen in der molekularen 
Schicht, zum ungerichteten Auswachsen von radialen Gliazellfasern und ektopisch 
liegenden zerebellären Körnerzellneuronen. Die Schlussfolgerung aus diesen Daten 
ist, dass die Expression von β1-Integrin in Körnerzellneuronen des Kleinhirns während 
dessen Entwicklung oder der Bildung von Medulloblastomen nicht essentiell ist. 
Vielmehr ist die Expression von β1-Integrin in Gliazellen entscheidend für die normale 
Entwicklung der Kleinhirnrinde. 
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